World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 6 May 2024
Main ID:  NCT02272309
Date of registration: 20/10/2014
Prospective Registration: No
Primary sponsor: Ulrich Mehnert
Public title: Neurophysiological Assessment of Healthy and Impaired Human Lower Urinary Tract Function
Scientific title:
Date of first enrolment: May 2014
Target sample size: 124
Recruitment status: Completed
URL:  https://clinicaltrials.gov/ct2/show/NCT02272309
Study type:  Interventional
Study design:  Allocation: Randomized. Intervention model: Single Group Assignment. Primary purpose: Basic Science. Masking: None (Open Label).  
Phase:  N/A
Countries of recruitment
Switzerland
Contacts
Key inclusion & exclusion criteria

Inclusion Criteria:

healthy volunteers:

- Written informed consent,

- good mental and physical health,

- age >18y,

Patients with LUTS and Patients with LUTS and treatment:

- Written informed consent,

- age >18y,

- prior urodynamic investigation,

- LUTS since >6months with or without detrusor overactivity

Exclusion Criteria:

healthy volunteers:

- any neurological or urological pathology,

- current pregnancy or lactation,

- urinary tract infection,

- hematuria,

- any previous pelvic or spine or craniocerebral surgery,

- any anatomical anomaly of the LUT or genitalia,

- any metabolic disease,

- any LUT malignancy,

- bladder capacity <150mL,

- SDV at 60mL;

Patients with LUTS and Patients with LUTS and treatment:

- current pregnancy or lactation,

- urinary tract infection,

- gross hematuria



Age minimum: 18 Years
Age maximum: 99 Years
Gender: All
Health Condition(s) or Problem(s) studied
Lower Urinary Tract Symptoms
Intervention(s)
Procedure: EEG and EP measurement
Primary Outcome(s)
N1latency of LUT SEPs [Time Frame: 2-3 measurements within 4-16 weeks from first exam]
Secondary Outcome(s)
Secondary ID(s)
KEK-ZH_2013-0518/PB_2016-00498
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history